Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events

被引:97
作者
Nardella, Caterina [1 ,2 ,3 ]
Chen, Zhenbang [1 ,2 ,3 ]
Salmena, Leonardo [1 ,2 ,3 ]
Carracedo, Arkaitz [1 ,2 ,3 ]
Alimonti, Andrea [1 ,2 ,3 ]
Egia, Ainara [1 ,2 ,3 ]
Carver, Brett [3 ,4 ]
Gerald, William [5 ]
Cordon-Cardo, Carlos [3 ,6 ]
Pandolfi, Pier Paolo [1 ,2 ,3 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ct,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[3] Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Urol, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[6] Columbia Univ, Dept Pathol, New York, NY 10032 USA
关键词
Rheb; Pten haploinsufficiency; prostate tumorigenesis; negative feedback loop; senescence;
D O I
10.1101/gad.1699608
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mammalian target of rapamycin ( mTOR) represents a critical signaling crossroad where pathways commonly disrupted in cancer converge. We report here that Rheb GTPase, the upstream activator of the mTOR complex 1 (mTORC1) is amplified in human prostate cancers. We demonstrate that Rheb overexpression promotes hyperplasia and a low-grade neoplastic phenotype in the mouse prostate while eliciting a concomitant senescence response and a negative feedback loop limiting Akt activation. Importantly, we show that Pten haploinsufficiency cooperates with Rheb overexpression to markedly promote prostate tumorigenesis. We conclude that Rheb acts as a proto-oncogene in the appropriate genetic milieu and signaling context.
引用
收藏
页码:2172 / 2177
页数:6
相关论文
共 31 条
[1]   Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38 [J].
Bai, Xiaochun ;
Ma, Dongzhu ;
Liu, Anling ;
Shen, Xiaoyun ;
Wang, Qiming J. ;
Liu, Yongjian ;
Jiang, Yu .
SCIENCE, 2007, 318 (5852) :977-980
[2]   Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis [J].
Chen, ZB ;
Trotman, LC ;
Shaffer, D ;
Lin, HK ;
Dotan, ZA ;
Niki, M ;
Koutcher, JA ;
Scher, HI ;
Ludwig, T ;
Gerald, W ;
Cordon-Cardo, C ;
Pandolfi, PP .
NATURE, 2005, 436 (7051) :725-730
[3]   Pten is essential for embryonic development and tumour suppression [J].
Di Cristofano, A ;
Pesce, B ;
Cordon-Cardo, C ;
Pandolfi, PP .
NATURE GENETICS, 1998, 19 (04) :348-355
[4]   Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse [J].
Di Cristofano, A ;
De Acetis, M ;
Koff, A ;
Cordon-Cardo, C ;
Pandolfi, PP .
NATURE GENETICS, 2001, 27 (02) :222-224
[5]   Breaking news: high-speed race ends in arrest - how oncogenes induce senescence [J].
Di Micco, Raffaella ;
Fumagalli, Marzia ;
di Fagagna, Fabrizio d'Adda .
TRENDS IN CELL BIOLOGY, 2007, 17 (11) :529-536
[6]   A BIOMARKER THAT IDENTIFIES SENESCENT HUMAN-CELLS IN CULTURE AND IN AGING SKIN IN-VIVO [J].
DIMRI, GP ;
LEE, XH ;
BASILE, G ;
ACOSTA, M ;
SCOTT, C ;
ROSKELLEY, C ;
MEDRANO, EE ;
LINSKENS, M ;
RUBELJ, I ;
PEREIRASMITH, O ;
PEACOCKE, M ;
CAMPISI, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9363-9367
[7]   mTOR and cancer therapy [J].
Easton, J. B. ;
Houghton, P. J. .
ONCOGENE, 2006, 25 (48) :6436-6446
[8]   Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling [J].
Gao, XS ;
Zhang, Y ;
Arrazola, P ;
Hino, O ;
Kobayashi, T ;
Yeung, RS ;
Ru, BG ;
Pan, DJ .
NATURE CELL BIOLOGY, 2002, 4 (09) :699-704
[9]   Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2 [J].
Garami, A ;
Zwartkruis, FJT ;
Nobukuni, T ;
Joaquin, M ;
Roccio, M ;
Stocker, H ;
Kozma, SC ;
Hafen, E ;
Bos, JL ;
Thomas, G .
MOLECULAR CELL, 2003, 11 (06) :1457-1466
[10]   Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN [J].
Gray, IC ;
Stewart, LMD ;
Phillips, SMA ;
Hamilton, JA ;
Gray, NE ;
Watson, GJ ;
Spurr, NK ;
Snary, D .
BRITISH JOURNAL OF CANCER, 1998, 78 (10) :1296-1300